Today: 19 April 2026
Browse Category

NSE:AEQUS 10 December 2025

Indian Stock Market Today, 10 December 2025: Sensex, Nifty Extend Losing Streak Ahead of Fed; Meesho Soars Over 50% on Debut

Indian Stock Market Today, 10 December 2025: Sensex, Nifty Extend Losing Streak Ahead of Fed; Meesho Soars Over 50% on Debut

The Sensex fell 275 points to 84,391.27 and the Nifty 50 dropped 81.65 points to 25,758 on Wednesday, marking a third straight decline. Broader markets underperformed, with midcaps and smallcaps posting steeper losses. Foreign investors sold ₹1,651 crore in equities, while domestic funds bought ₹3,752 crore. The rupee closed at 89.97 per US dollar, near record lows.
10 December 2025
Aequs Ltd (AEQUS) IPO Listing 10 December 2025: 13% Premium Debut, Share Price Today, Broker Views and Outlook

Aequs Ltd (AEQUS) IPO Listing 10 December 2025: 13% Premium Debut, Share Price Today, Broker Views and Outlook

Aequs Ltd shares debuted at ₹140 on NSE and BSE Wednesday, 12.9% above the ₹124 IPO price, valuing the company at about ₹9,500 crore. By early afternoon, the stock traded near ₹142.3, up nearly 15% from issue price, with over 75 lakh shares and ₹100 crore turnover on BSE. Intraday prices ranged from ₹135.4 to ₹151 amid volatile trade. The listing fell short of grey-market expectations of a ₹155 debut.
10 December 2025
Aequs IPO Listing Today: Share Price Jumps 13% on Debut – Allotment Status, GMP, Subscription and Business Model Explained

Aequs IPO Listing Today: Share Price Jumps 13% on Debut – Allotment Status, GMP, Subscription and Business Model Explained

Aequs Limited shares listed at ₹140 on NSE and BSE, a 12.9% premium over the ₹124 IPO price, on December 10. The ₹921.81 crore IPO was subscribed 101.63 times, with strong demand from institutional and retail investors. A retail allotment of 120 shares saw a notional gain of about ₹1,920 per lot at listing. Book-running lead managers included JM Financial, IIFL Capital, and Kotak Mahindra.

Stock Market Today

  • Alcoa Stock Seen Undervalued Despite Recent Pullback, DCF Model Shows 46% Discount
    April 18, 2026, 10:57 PM EDT. Alcoa's shares have surged 184.5% over the past year but fell 10.1% in the last week, raising questions about its valuation. A Discounted Cash Flow (DCF) analysis estimates an intrinsic value of $122.18 per share, suggesting the stock trades at a 46.3% discount to its recent price of $65.62. This indicates potential undervaluation despite market volatility. Alcoa scored 5 out of 6 on a value metric, reflecting positive valuation signals amid commodity sector sensitivity. Investors should consider Alcoa's position within the materials sector and its exposure to cyclicals when assessing risk and reward. The price-to-earnings (P/E) ratio also offers insight into market expectations for growth and risk relative to peers. Overall, Alcoa presents a notable opportunity for value-conscious investors.

Latest article

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

Why Definium Therapeutics’ LSD-Based Drug Has Wall Street Watching 2026

18 April 2026
Definium Therapeutics shares rose to $22.68 after Stifel and Piper Sandler initiated coverage with Buy ratings, citing late-stage trials of DT120, an LSD-based tablet for anxiety and depression. The company will host an investor day April 22 in New York to discuss upcoming Phase 3 data. DT120 is in four pivotal studies, with top-line results expected through 2026. Johnson & Johnson and Compass Pathways are advancing rival clinic-based psychiatric drugs.
Go toTop